Skip to main content

Blanks Robert's Form 4 filing

Ardelyx, Inc. (ARDX) · filed Jun 27, 2023

Accession no.
0001628280-23-023651
Filed
Jun 27, 2023
Trade date
Jun 23, 2023
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $121.0K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blanks RobertCIK 0001815433Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 23, 2023Common StockMOption exerciseAcquired+33,333$3.42+$113,998.86299,467Direct
Jun 23, 2023Common StockSSaleDisposed−33,333$3.63F2−$120,998.79266,134Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 23, 2023Common StockMOption exerciseDisposed−33,333$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades in prices ranging from $3.62 to $3.70, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Remarks

Chief Regulatory and Quality Affairs Officer

Read the full filing on SEC EDGAR (opens in a new tab)